Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

Authors

Mikhail Binnewies

Published

October 1, 2021

Abstract

Converting checkpoint inhibitor (CPI)-resistant individuals to being responsive requires identifying suppressive mechanisms. We identify TREM2

Supporters

Support the authors with ResearchCoin

Journal

Cell Reports

Topics

Tumor-Infiltrating Lymphocytes

DOI

10.1016/j.celrep.2021.109844

License

CC-BY

Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

Authors

Mikhail Binnewies

Published

October 1, 2021

Abstract

Converting checkpoint inhibitor (CPI)-resistant individuals to being responsive requires identifying suppressive mechanisms. We identify TREM2

Supporters

Support the authors with ResearchCoin

Journal

Cell Reports

Topics

Tumor-Infiltrating Lymphocytes

DOI

10.1016/j.celrep.2021.109844

License

CC-BY

Paper

Paper

Paper

Paper

Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

Abstract

Supporters

Journal

Topics

DOI

License

Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

Abstract

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License